Warning letterPosted June 3, 2025

FDA warning letter to La Milagrosa 1 LLC

CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food/Adulterated

FDA's record ↗

FDA posted a warning letter to La Milagrosa 1 LLC on June 3, 2025; the letter is dated April 7, 2025. Subject: CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food/Adulterated. Issuing office: Human Foods Program.

On the record

Company
La Milagrosa 1 LLC
Subject
CGMP/Hazard Analysis/Risk-Based Preventive Controls for Food/Adulterated
Issuing office
Human Foods Program
Letter dated
2025-04-07
Posted by FDA
2025-06-03
Source
FDA warning letters ↗

CFR cited

The record cites 11 sections of 21 CFR Part 117.

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch La Milagrosa 1 LLC

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with La Milagrosa 1 LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.